Literature DB >> 8542509

Hepatoid adenocarcinoma of the stomach: a case report.

C Ihling1, H E Schaefer, U Baumgartner, U N Riede.   

Abstract

A case of primarily inoperable hepatoid adenocarcinoma of the stomach is reported, which, after chemotherapy with farmorubicin, 5-fluorouracil and leucovorin, showed an impressive regression resulting in an improvement of the overall condition of the patient and a decrease of the serum AFP level from initially 79.120 ng/ml to 3.728 ng/ml. In a second operation the tumor was removed and intraoperative radiation therapy was applied to the head of the pancreas and intraabdominal lymph nodes. Furthermore, we discuss the main pathologic features of this rare tumor entity and give a short review of the literature.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8542509

Source DB:  PubMed          Journal:  Gen Diagn Pathol        ISSN: 0947-823X


  4 in total

1.  Gastric Hepatoid Carcinoma Presenting Initially as GIST on CT Scan.

Authors:  Baotram Tran; James Ouellette
Journal:  Gastrointest Cancer Res       Date:  2012-05

2.  Alpha-fetoprotein-producing adenocarcinoma in which the metastatic route was determined from calcified lesions.

Authors:  Atsunori Tsuchiya; Tsutomu Kanefuji; Takeshi Suda; Tomoya Aoyagi; Akihiko Osaki; Tadayuki Togashi; Yusuke Kawauchi; Mae Fushiki; Gen Watanabe; Masaki Hirota; Minoru Nomoto; Yoichi Ajioka; Yutaka Aoyagi
Journal:  Clin J Gastroenterol       Date:  2011-02-25

3.  Successful paclitaxel-based chemotherapy for an alpha-fetoprotein-producing gastric cancer patient with multiple liver metastases.

Authors:  Hiromitsu Takeyama; Hirozumi Sawai; Takehiro Wakasugi; Hiroki Takahashi; Yoichi Matsuo; Nobuo Ochi; Akira Yasuda; Mikinori Sato; Yuji Okada; Hitoshi Funahashi; Yoshimi Akamo; Tadao Manabe
Journal:  World J Surg Oncol       Date:  2007-07-16       Impact factor: 2.754

4.  Alpha-fetoprotein-producing nonmetastatic gastric adenocarcinoma: a rare entity.

Authors:  A Vivekanandarajah; J P Atallah; S Gupta
Journal:  J Gastrointest Cancer       Date:  2014-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.